ACTOS Drug Patent Profile
✉ Email this page to a colleague
When do Actos patents expire, and when can generic versions of Actos launch?
Actos is a drug marketed by Takeda Pharms Usa and is included in one NDA.
The generic ingredient in ACTOS is pioglitazone hydrochloride. There are twenty-seven drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the pioglitazone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Actos
A generic version of ACTOS was approved as pioglitazone hydrochloride by CHARTWELL RX on October 26th, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ACTOS?
- What are the global sales for ACTOS?
- What is Average Wholesale Price for ACTOS?
Summary for ACTOS
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 145 |
Patent Applications: | 2,813 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ACTOS |
Drug Sales Revenues: | Drug sales revenues for ACTOS |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ACTOS |
What excipients (inactive ingredients) are in ACTOS? | ACTOS excipients list |
DailyMed Link: | ACTOS at DailyMed |
![ACTOS drug patent expirations Drug patent expirations by year for ACTOS](/p/graph/s/t/ACTOS-patent-expirations.png)
![Drug Prices for ACTOS](/p/graph/drug-price/ACTOS.png)
![Drug Sales Revenue Trends for ACTOS](/p/graph/drug-sales-revenues/ACTOS.png)
US Patents and Regulatory Information for ACTOS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Takeda Pharms Usa | ACTOS | pioglitazone hydrochloride | TABLET;ORAL | 021073-001 | Jul 15, 1999 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Takeda Pharms Usa | ACTOS | pioglitazone hydrochloride | TABLET;ORAL | 021073-002 | Jul 15, 1999 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Takeda Pharms Usa | ACTOS | pioglitazone hydrochloride | TABLET;ORAL | 021073-003 | Jul 15, 1999 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ACTOS
International Patents for ACTOS
See the table below for patents covering ACTOS around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Greece | 860124 | THIAZOLIDINE DERIVATIVES METHOD FOR THEIR PREPARATION AND THEIR APPLICATION | ⤷ Sign Up |
Norway | 2007001 | ⤷ Sign Up | |
Austria | 41931 | ⤷ Sign Up | |
European Patent Office | 1174135 | Composition pharmaceutique comprenant de pioglitazone et du glimepiride pour utilisation dans le traitement du diabète (Pharmaceutical composition comprising pioglitazone and glimepiride for use in treatment of diabetes) | ⤷ Sign Up |
Germany | 69637988 | ⤷ Sign Up | |
South Korea | 920010046 | ⤷ Sign Up | |
Japan | 3973280 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ACTOS
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1174135 | C01174135/01 | Switzerland | ⤷ Sign Up | FORMER REPRESENTATIVE: BOHEST AG, CH |
0861666 | C00861666/01 | Switzerland | ⤷ Sign Up | FORMER REPRESENTATIVE: BOHEST AG, CH |
0861666 | CA 2007 00001 | Denmark | ⤷ Sign Up | |
0861666 | 07C0006 | France | ⤷ Sign Up | PRODUCT NAME: PIOGLITAZONE/METFORMINE ET LEURS SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE IN FRANCE: EU/1/06/354/001 DU 20060728; REGISTRATION NO/DATE AT EEC: EU/1/06/354/001 DU 20060728 |
0193256 | C300038 | Netherlands | ⤷ Sign Up | PRODUCT NAME: PIOGLITAZON, DESGEWENST IN DE VORM VAN EEN FARMACOLOGISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER HET HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/00/151/001 - EU/1/00/151/006 20001011 |
0861666 | 300258 | Netherlands | ⤷ Sign Up | 300258, 20160620, EXPIRES: 20210619 |
1174135 | 437 | Finland | ⤷ Sign Up | |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |